Ardent Health, Inc. has recharacterized the June 2, 2026 departure of former President and CEO Martin J. Bonick as a termination "for Cause." This decision, made by the Board of Directors on October 19, 2026, follows the discovery that Mr. Bonick failed to fully disclose third-party compensation. As a result, the company will discontinue remaining severance payments and benefits.
Key Details
- Financial Impact: The company will halt approximately $4.5 million in unpaid cash severance and cancel all outstanding unvested performance-based restricted stock units (PRSUs) previously granted to Mr. Bonick.
- Reason for Reclassification: The Board's determination followed a review where it found Mr. Bonick had failed to report compensation received from third parties, which was required by company policy.
- Financial Reporting: Ardent Health stated that none of its previously issued financial statements or results require revision or correction due to this matter.